| Kelly Marcus Coleman, MD | |
|
6300 E Lake Blvd Ste 201, Vancleave, MS 39565-6771 | |
| (228) 230-2663 | |
| (228) 546-3257 |
| Full Name | Kelly Marcus Coleman |
|---|---|
| Gender | Male |
| Speciality | Pain Management |
| Experience | 14 Years |
| Location | 6300 E Lake Blvd Ste 201, Vancleave, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629395454 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 25293 (Mississippi) | Secondary |
| 208VP0014X | Pain Medicine - Interventional Pain Medicine | 25293 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Singing River Health System | Pascagoula, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bienville Orthopaedic Specialists, Llc | 0547155178 | 47 |
News Archive
Many Americans, with the start of the New Year, will resolve to cut back on fast food to avoid an overload of fat and calories.
The HEALTHY FUTURES project is coordinating a conference to bring together researchers at the cutting edge of efforts to understand relationships between climate change and vector-borne diseases. The conference will be held in Kigali, Rwanda, on 18-20 November 2014.
Research published today (Feb. 11, 2019) reveals how one mutation causes fragile X, the most common inherited intellectual disability.
Last week, a group of 55 U.S. physicians sent a letter to the U.S. Food & Drug Administration (FDA), urging the agency not to approve the use of Gilead's HIV/AIDS treatment drug Truvada for use as an HIV prevention pill - also known as "pre-exposure prophylaxis" (PrEP).
In Humanosphere, journalist Tom Paulson examines Rwanda's recent success in implementing a health "insurance program that has covered most of the population with an emphasis on basic, preventative care."
› Verified 9 days ago
| Entity Name | Bienville Orthopaedic Specialists, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689605834 PECOS PAC ID: 0547155178 Enrollment ID: O20040220000834 |
News Archive
Many Americans, with the start of the New Year, will resolve to cut back on fast food to avoid an overload of fat and calories.
The HEALTHY FUTURES project is coordinating a conference to bring together researchers at the cutting edge of efforts to understand relationships between climate change and vector-borne diseases. The conference will be held in Kigali, Rwanda, on 18-20 November 2014.
Research published today (Feb. 11, 2019) reveals how one mutation causes fragile X, the most common inherited intellectual disability.
Last week, a group of 55 U.S. physicians sent a letter to the U.S. Food & Drug Administration (FDA), urging the agency not to approve the use of Gilead's HIV/AIDS treatment drug Truvada for use as an HIV prevention pill - also known as "pre-exposure prophylaxis" (PrEP).
In Humanosphere, journalist Tom Paulson examines Rwanda's recent success in implementing a health "insurance program that has covered most of the population with an emphasis on basic, preventative care."
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kelly Marcus Coleman, MD 6300 E Lake Blvd Ste 301, Vancleave, MS 39565-6771 Ph: (228) 230-2663 | Kelly Marcus Coleman, MD 6300 E Lake Blvd Ste 201, Vancleave, MS 39565-6771 Ph: (228) 230-2663 |
News Archive
Many Americans, with the start of the New Year, will resolve to cut back on fast food to avoid an overload of fat and calories.
The HEALTHY FUTURES project is coordinating a conference to bring together researchers at the cutting edge of efforts to understand relationships between climate change and vector-borne diseases. The conference will be held in Kigali, Rwanda, on 18-20 November 2014.
Research published today (Feb. 11, 2019) reveals how one mutation causes fragile X, the most common inherited intellectual disability.
Last week, a group of 55 U.S. physicians sent a letter to the U.S. Food & Drug Administration (FDA), urging the agency not to approve the use of Gilead's HIV/AIDS treatment drug Truvada for use as an HIV prevention pill - also known as "pre-exposure prophylaxis" (PrEP).
In Humanosphere, journalist Tom Paulson examines Rwanda's recent success in implementing a health "insurance program that has covered most of the population with an emphasis on basic, preventative care."
› Verified 9 days ago